✦ LIBER ✦

Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A

✍ Scribed by A. M. MULLAH-ALI; A. K. CHAN; D. LILLICRAP; K. DECKER; W. SEROSKI; K. MOFFAT; I. WALKER; M. K. PAI

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Optivate®, a high-pu

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Immune tolerance induction with a factor

✍ C. BIDLINGMAIER; K. KURNIK; C. ESCURIOLA-ETTINGSHAUSEN; R. JAGER; R. KLAMROTH; C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Immune tolerance therapy utilizing facto

✍ M. A. H. KURTH; D. DIMICHELE; C. SEXAUER; J. M. SANDERS; M. TORRES; S. C. ZAPPA; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Treatment of acute haemorrhage in a pati

✍ A. Dietrich; U. Scholz; D. Schreiter 📂 Article 📅 2005 🏛 Blackwell Publishing 🌐 German ⚖ 96 KB

Clinical assessment of Optivate®, a high

✍ A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Higher recovery of factor VIII (FVIII) w

✍ T. INOUE; M. SHIMA; M. TAKEYAMA; T. MATSUMOTO; K. NISHIYA; I. TANAKA; Y. SAKURAI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB